Published Date: 08 Mar 2023
Every year, tap burns in the United States come at a high personal and financial cost, according to an analysis of nationally significant data published online in the Journal Injury Prevention.
Read Full NewsPhase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.
Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.
Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years
Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism
1.
Researchers discover cellular 'doorway' exploited by cancer-causing virus
2.
Elder Abuse: Red Flags to Look Out For While Receiving Care.
3.
Guideline on management of early-stage non-small cell lung cancer released
4.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
5.
Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy
1.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
2.
Digital Oncology Command Platforms for Longitudinal Cancer Care Coordination
3.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
4.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
5.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Signs and Symptoms of Leukemia
4.
A New Era in Managing Cancer-Associated Thrombosis
5.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation